- Who can participate: Adults aged 18-65 who experience chronic migraines, defined as 15 or more headache days per month, may be eligible to participate. Additional criteria include a history of migraines for at least one year and stable medication use for the past month.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. They will attend regular clinic visits for assessments and report their migraine occurrences through a digital diary.